Prospective Randomized, Double Blind, Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess
Latest Information Update: 08 Jul 2017
At a glance
- Drugs Pasireotide (Primary)
- Indications Abscess; Digestive system fistula; Postoperative complications
- Focus Therapeutic Use
- 03 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jun 2014 New trial record
- 03 Jun 2014 Quality of life outcomes presented at the 50th Annual Meeting of the American Society of Clinical Oncology.